EFFECTS OF TRIMETHOPRIM AND SULPHONAMIDE PREPARATIONS ON THE PITUITARY–THYROID AXIS OF RODENTS

in Journal of Endocrinology
Authors:
H. N. COHEN
Search for other papers by H. N. COHEN in
Current site
Google Scholar
PubMed
Close
,
J. A. FYFFE
Search for other papers by J. A. FYFFE in
Current site
Google Scholar
PubMed
Close
,
W. A. RATCLIFFE
Search for other papers by W. A. RATCLIFFE in
Current site
Google Scholar
PubMed
Close
,
A. M. McNICOL
Search for other papers by A. M. McNICOL in
Current site
Google Scholar
PubMed
Close
,
H. McINTYRE
Search for other papers by H. McINTYRE in
Current site
Google Scholar
PubMed
Close
,
J. S. KENNEDY
Search for other papers by J. S. KENNEDY in
Current site
Google Scholar
PubMed
Close
, and
J. A. THOMSON
Search for other papers by J. A. THOMSON in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

The effects on pituitary–thyroid function of the commonly prescribed anti-bacterial preparations co-trimoxazole and co-trifamole, and their component drugs, have been studied in the rat and compared to the changes caused by propylthiouracil.

Co-trimoxazole and co-trifamole, in doses 20-fold in excess of a pharmacological dose administered for 10 days, produced marked changes in hormone levels consistent with blocking of thyroidal activity. Significant increases in thyroid gland weight, with histological evidence of hyperplastic goitre formation, were also demonstrated. Propylthiouracil produced less marked changes of thyroid hormone levels but higher levels of thyroid-stimulating hormone. Pharmacological doses of co-trimoxazole and co-trifamole and sulphamoxole, the sulphonamide component of co-trifamole, caused significant changes in thyroid hormone levels consistent with anti-thyroidal activity. In contrast, there was no evidence that trimethoprim, which is common to both preparations, or sulphamethoxazole, the sulphonamide component of co-trimoxazole, had an anti-thyroidal action, indeed, serum thyroxine levels were significantly increased at pharmacological dosage. We have concluded that the new commonly prescribed combination preparations retain the goitrogenic properties of the earlier sulphonamides.

 

  • Collapse
  • Expand